We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $875B
1-Year Est. Return 40.91%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
+3.75%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$218B
AUM Growth
+$17B
Cap. Flow
+$6.68B
Cap. Flow %
3.06%
Top 10 Hldgs %
22.81%
Holding
10,425
New
1,217
Increased
3,775
Reduced
3,854
Closed
1,335

Top Buys

Rank Stock Value
1
NFLX icon
Netflix
NFLX
+$400M
2
C icon
Citigroup
C
+$395M
3
CELG
Celgene Corp
CELG
+$360M
4
AMZN icon
Amazon
AMZN
+$347M
5
RTX icon
RTX Corp
RTX
+$344M

Sector Composition

Rank Sector Weight
1 Technology 5.61%
2 Financials 4.93%
3 Healthcare 4%
4 Consumer Discretionary 3.82%
5 Industrials 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZN
8451
DELISTED
Horizon Global Corporation
HZN
$69K ﹤0.01%
19,258
-37,961
-66% -$124K
RUHN
8452
DELISTED
Ruhnn Holding Limited American Depositary Shares
RUHN
$69K ﹤0.01%
+20,042
New +$103K
MOBL
8453
PUT
DELISTED
MobileIron, Inc.
MOBL
$69K ﹤0.01%
+11,100
New +$62.8K
ALDX icon
8454
Aldeyra Therapeutics
ALDX
$94.1M
$68K ﹤0.01%
11,405
-21,503
-65% -$162K
LUMO
8455
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$68K ﹤0.01%
5,136
+1,810
+54% +$27.3K
GNCA
8456
DELISTED
Genocea Biosciences, Inc.
GNCA
$68K ﹤0.01%
+17,290
New +$90.2K
LAC
8457
DELISTED
Lithium Americas Corp. Common Shares
LAC
$68K ﹤0.01%
16,735
+4,301
+35% +$17K
ABEV icon
8458
PUT
Ambev
ABEV
$43.2B
$67K ﹤0.01%
+14,300
New +$64.1K
QUIK icon
8459
QuickLogic
QUIK
$234M
$67K ﹤0.01%
8,310
-1,418
-15% -$14.3K
TTNP
8460
CALL
DELISTED
Titan Pharmaceuticals
TTNP
$67K ﹤0.01%
87
+11
+14% +$10.1K
ACER
8461
DELISTED
Acer Therapeutics Inc
ACER
$67K ﹤0.01%
+17,078
New +$325K
NBRV
8462
PUT
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$67K ﹤0.01%
+110
New +$67.5K
AGEN
8463
PUT
Agenus
AGEN
$329M
$66K ﹤0.01%
1,116
-1,212
-52% -$66.2K
BCLI
8464
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$66K ﹤0.01%
1,121
+194
+21% +$11.3K
ADMS
8465
PUT
DELISTED
Adamas Pharmaceuticals
ADMS
$66K ﹤0.01%
10,600
-400
-4% -$2.3K
IGC icon
8466
IGC Pharma
IGC
$31.1M
$65K ﹤0.01%
+39,579
New +$55.9K
SJT
8467
PUT
San Juan Basin Royalty Trust
SJT
$131M
$65K ﹤0.01%
16,900
-20,200
-54% -$89.4K
SLDB icon
8468
PUT
Solid Biosciences
SLDB
$986M
$64K ﹤0.01%
747
-220
-23% -$24K
AUC
8469
ATIF Holdings
AUC
$72M
$64K ﹤0.01%
+213
New +$74.8K
HTGM
8470
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
$64K ﹤0.01%
214
+130
+155% +$54.2K
MR
8471
CALL
DELISTED
Montage Resources Corporation Common Stock
MR
$63K ﹤0.01%
10,300
-20,400
-66% -$203K
AVDL
8472
PUT
DELISTED
Avadel Pharmaceuticals
AVDL
$62K ﹤0.01%
+21,600
New +$37.1K
ITI
8473
DELISTED
Iteris, Inc.
ITI
$62K ﹤0.01%
+11,864
New +$56.9K
TTOO
8474
DELISTED
T2 Biosystems, Inc
TTOO
$62K ﹤0.01%
+7
New +$82K
ENT
8475
DELISTED
Global Eagle Entertainment Inc.
ENT
$61K ﹤0.01%
3,748
-566
-13% -$10.2K

Similar funds

Citadel Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Citadel Advisors held 10,425 positions worth $218B, up 8.5% from $201B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Citadel Advisors deployed $6.68B of net new capital in Q2 2019, opening 1,217 new positions and adding to 3,775 existing holdings. Its largest new stake was Uber: 7,077,910 shares worth $328M.

By sector, the portfolio is most concentrated in Technology at 5.6% of assets, down from 6% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Eli Lilly, an estimated $397M trimmed.

  • Citadel Advisors's largest Q2 2019 buy was Uber: 7,077,910 shares worth $328M.
  • Citadel Advisors added most to Netflix in Q2 2019, an estimated $400M increase.
  • Citadel Advisors's biggest Q2 2019 reduction was Eli Lilly, cutting an estimated $397M.
  • Citadel Advisors fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $349M.
  • Citadel Advisors's ten largest holdings make up 23% of its $218B portfolio in Q2 2019.
  • Citadel Advisors opened 1,217 new positions and closed 1,335 in Q2 2019.
  • Citadel Advisors's portfolio value rose 8.5% quarter-over-quarter to $218B.

Based on Citadel Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.